Priapism: New concepts in the pathophysiology and new treatment strategies

被引：41

作者：

Bivalacqua T.J. ^{[1
]}

Burnett A.L. ^{[1
]}

机构：

[1] James Buchanan Brady Urological Institute, Johns Hopkins Hospital, Marburg 407, Baltimore, MD 21287, 600 N, Wolfe Avenue

来源：

Current Urology Reports | 2006年 / 7卷 / 6期

关键词：

Erectile Dysfunction; Sickle Cell Disease; Priapism; Penile Erection; Corporal Smooth Muscle;

D O I：

10.1007/s11934-006-0061-6

中图分类号：

学科分类号：

摘要：

Priapism is defined as prolonged and persistent erection of the penis without sexual stimulation. This is a poorly understood disease process, and we have little information on the etiology and pathophysiology of this erectile disorder. Two main types of priapism exist: low-flow (ischemic) and high-flow (nonischemic) priapism. When the physician first diagnoses which type of priapism exists, distinguishing the type of priapic event is paramount in order to choose the correct treatment options. Until recently, we had not sufficiently understood the pathogenesis of this erectile disorder and therefore, could not effectively manage its pathologic consequences of erectile tissue damage and erectile dysfunction. In this review, the proposed pathogenesis of ischemic priapism is reviewed, and a survey regarding novel treatment modalities is given. Copyright © 2006 by Current Science Inc.

引用

页码：497 / 502

页数：5

共 43 条

[1]

Spycher M.A., Hauri D., The ultrastructure of the erectile tissue in priapism, J Urol, 135, pp. 142-147, (1986)

[2]

Melman A., Serels S., Priapism, Int J Impot Res, 12, SUPPL. 4, (2000)

[3]

Burnett A.L., Pathophysiology of priapism: Dysregulatory erection physiology thesis, J Urol, 170, pp. 26-34, (2003)

[4]

Van Der Horst C., Stuebinger H., Seif C., Et al., Priapism-etiology, pathophysiology and management, Int Braz J Urol, 29, pp. 391-400, (2003)

[5]

Berger R., Billups K., Brock G., Et al., Report of the American Foundation for Urologic Disease (AFUD) thought leader panel for evaluation and treatment of priapism, Int J Impot Res, 13, SUPPL. 5, (2001)

[6]

Broderick G.A., Harkaway R., Pharmacologic erection: Time-dependent changes in corporal environment, Int J Impot Res, 6, pp. 9-16, (1994)

[7]

Kulmala R., Lehtonen T., Tammela T.L., Priapism, its incidence and seasonal disturbances in Finland, Scand J Urol Nephrol, 29, pp. 93-96, (1995)

[8]

Eland I.A., Van Der Lei J., Stricker B.H.C., Sturkenboom M.J.C.M., Incidence of priapism in the general population, Urology, 57, pp. 970-972, (2001)

[9]

Earle C.M., Stuckey B.G.A., Ching H.L., Wisniewski Z.S., The incidence and management of priapism in western Australia: A 16 year audit, Int J Impot Res, 15, pp. 272-276, (2003)

[10]

Adeyoju A.B., Olujohungbe A.B.K., Morris J., Et al., Priapism in sickle cell disease

← 1 2 3 4 5 →